The CDC is offering approximately $7 million in competitive supplemental funding to 32 health department jurisdictions currently receiving Ending the HIV Epidemic (EHE) initiative resources. This grant aims to accelerate Pre-Exposure Prophylaxis (PrEP) uptake, working towards the national goal of 50% PrEP coverage by 2025. Resources target jurisdictions with greater PrEP need and lower uptake among priority populations, including Black and Latino gay, bisexual, and other men who have sex with men (MSM), and Black cisgender and transgender women. Funding supports enhanced activities like patient navigation, improving access to PrEP services, and eliminating structural barriers. Additionally, programs will increase awareness and access to HIV non-occupational post-exposure prophylaxis (PEP) and doxycycline post-exposure prophylaxis (doxy PEP).
Opportunity ID: 355421
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-PS-24-00470101SUPP24 |
| Funding Opportunity Title: | High-Impact HIV Prevention and Surveillance Programs for Health Departments: Accelerating Pre-Exposure Prophylaxis (PrEP) Uptake for Ending the HIV Epidemic in the United States |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.940 — HIV Prevention Activities Health Department Based |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 01, 2024 |
| Last Updated Date: | Aug 01, 2024 |
| Original Closing Date for Applications: | Aug 31, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | Aug 31, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Sep 30, 2024 |
| Estimated Total Program Funding: | $1,750,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | State governments County governments City or township governments Special district governments |
| Additional Information on Eligibility: | Due to statutory authority, this supplemental funding opportunity is offered to the 32 state, local and territorial health departments currently receiving Ending the HIV Epidemic in the U.S. (EHE) funding under notice of funding opportunity (NOFO) PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments. |
Additional Information
| Agency Name: | Centers for Disease Control – NCHHSTP |
| Description: | CDC announces the availability of approximately $7 million in competitive supplemental funding for the 32 health department jurisdictions currently receiving Ending the HIV Epidemic in the US (EHE) initiative funding resources under notice of funding opportunity (NOFO) PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments. Fully aligned with PS24-0047, the supplemental NOFO prioritizes acceleration of progress toward achieving the national HIV prevention goal of 50% pre-exposure prophylaxis (PrEP) coverage by the end of 2025. Jurisdictions with greater need for PrEP and lower uptake among priority populations disproportionately affected by HIV and low PrEP prescriptions (i.e., Black and Latino gay, bisexual, and other men who have sex with men (MSM), and Black cisgender and transgender women) need these additional resources and flexibility to accelerate PrEP uptake through patient navigation/case management services and improve access to and utilization of existing PrEP services not covered by other financial resources. Recipients will implement enhanced and expanded programmatic activities to increase access to and uptake of PrEP for priority populations and to help further eliminate structural and social barriers that prevent equitable access to PrEP within EHE jurisdictions. Additionally, these enhanced and expanded PrEP programs will incorporate elements to increase HIV non-occupational post-exposure prophylaxis (PEP) and doxycycline post-exposure prophylaxis (doxy PEP) awareness and access, including activities with clinicians, non-clinical community-based organizations (CBOs), and persons at risk for HIV acquisition.The supplemental NOFO’s period of performance is September 30, 2024 – May 31, 2025 (8 months). Recipients may request to continue implementation of supplemental programmatic activities during PS24-0047 Budget Year 2 (June 1, 2025 – May 31, 2026). Recipients will implement concurrently all required programmatic activities as described in both PS24-0047 and the forthcoming supplemental NOFO. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Erica K. Dunbar
NOFOINFO@cdc.gov Email:NOFOINFO@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 355421 Full Announcement-Full Announcement -> Foa_Content_of_CDC-RFA-PS-24-00470101SUPP24.pdf
Packages
| Agency Contact Information: | Erica K. Dunbar NOFOINFO@cdc.gov Email: NOFOINFO@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.940 | CDC-RFA-PS-24-00470101SUPP24 | High-Impact HIV Prevention and Surveillance Programs for Health Departments: Accelerating Pre-Exposure Prophylaxis (PrEP) Uptake for Ending the HIV Epidemic in the United States | PKG00287555 | Aug 01, 2024 | Aug 31, 2024 | View |
Package 1
Mandatory forms
355421 SF424_4_0-4.0.pdf
355421 SF424A-1.0.pdf
355421 BudgetNarrativeAttachments_1_2-1.2.pdf
355421 ProjectNarrativeAttachments_1_2-1.2.pdf
355421 Project_Abstract_1_2-1.2.pdf
355421 Project_AbstractSummary_2_0-2.0.pdf
355421 SFLLL_2_0-2.0.pdf
Optional forms
355421 OtherNarrativeAttachments_1_2-1.2.pdf